Axcan Pharma (NASDAQ: AXCA) announced that it has submitted an amendment to its New Drug Application (NDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE